Cargando…
COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension
Introduction: Coronavirus disease 2019 (COVID-19) has multiorgan involvement and its severity varies with the presence of pre-existing risk factors like cardiovascular disease (CVD) and hypertension (HTN). Therefore, it is important to evaluate their effect on outcomes of COVID-19 patients. The obje...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980770/ https://www.ncbi.nlm.nih.gov/pubmed/33763316 http://dx.doi.org/10.7759/cureus.13420 |
_version_ | 1783667489559805952 |
---|---|
author | Chakinala, Raja Chandra Shah, Chail D Rakholiya, Jigisha H Martin, Mehwish Kaur, Nirmaljot Singh, Harmandeep Okafor, Toochukwu L Nwodika, Chika Raval, Payu Yousuf, Salma Lakhani, Komal Yogarajah, Angelina Malik, Preeti Singh, Jagmeet Kichloo, Asim Patel, Urvish K |
author_facet | Chakinala, Raja Chandra Shah, Chail D Rakholiya, Jigisha H Martin, Mehwish Kaur, Nirmaljot Singh, Harmandeep Okafor, Toochukwu L Nwodika, Chika Raval, Payu Yousuf, Salma Lakhani, Komal Yogarajah, Angelina Malik, Preeti Singh, Jagmeet Kichloo, Asim Patel, Urvish K |
author_sort | Chakinala, Raja Chandra |
collection | PubMed |
description | Introduction: Coronavirus disease 2019 (COVID-19) has multiorgan involvement and its severity varies with the presence of pre-existing risk factors like cardiovascular disease (CVD) and hypertension (HTN). Therefore, it is important to evaluate their effect on outcomes of COVID-19 patients. The objective of this meta-analysis and meta-regression is to evaluate outcomes of COVID-19 amongst patients with CVD and HTN. Methods: English full-text observational studies having data on epidemiological characteristics of patients with COVID-19 were identified searching PubMed from December 1, 2019, to July 31, 2020, following Meta-analysis Of Observational Studies in Epidemiology (MOOSE) protocol. Studies having pre-existing CVD and HTN data that described outcomes including mortality and invasive mechanical ventilation (IMV) utilization were selected. Using random-effects models, risk of composite poor outcomes (meta-analysis) and isolated mortality and IMV utilization (meta-regression) were evaluated. Pooled prevalence of CVD and HTN, correlation coefficient (r) and odds ratio (OR) were estimated. The forest plots and correlation plots were created using random-effects models. Results: Out of 29 studies (n=27,950) that met the criteria, 28 and 27 studies had data on CVD and HTN, respectively. Pooled prevalence of CVD was 18.2% and HTN was 32.7%. In meta-analysis, CVD (OR: 3.36; 95% CI: 2.29-4.94) and HTN (OR: 1.94; 95% CI: 1.57-2.40) were associated with composite poor outcome. In age-adjusted meta-regression, pre-existing CVD was having significantly higher correlation of IMV utilization (r: 0.28; OR: 1.3; 95% CI: 1.1-1.6) without having any association with mortality (r: -0.01; OR: 0.9; 95% CI: 0.9-1.1) among COVID-19 hospitalizations. HTN was neither correlated with higher IMV utilization (r: 0.01; OR: 1.0; 95% CI: 0.9-1.1) nor correlated with higher mortality (r: 0.001; OR: 1.0; 95% CI: 0.9-1.1). Conclusion: In age-adjusted analysis, though we identified pre-existing CVD as a risk factor for higher utilization of mechanical ventilation, pre-existing CVD and HTN had no independent role in increasing mortality. |
format | Online Article Text |
id | pubmed-7980770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-79807702021-03-23 COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension Chakinala, Raja Chandra Shah, Chail D Rakholiya, Jigisha H Martin, Mehwish Kaur, Nirmaljot Singh, Harmandeep Okafor, Toochukwu L Nwodika, Chika Raval, Payu Yousuf, Salma Lakhani, Komal Yogarajah, Angelina Malik, Preeti Singh, Jagmeet Kichloo, Asim Patel, Urvish K Cureus Cardiology Introduction: Coronavirus disease 2019 (COVID-19) has multiorgan involvement and its severity varies with the presence of pre-existing risk factors like cardiovascular disease (CVD) and hypertension (HTN). Therefore, it is important to evaluate their effect on outcomes of COVID-19 patients. The objective of this meta-analysis and meta-regression is to evaluate outcomes of COVID-19 amongst patients with CVD and HTN. Methods: English full-text observational studies having data on epidemiological characteristics of patients with COVID-19 were identified searching PubMed from December 1, 2019, to July 31, 2020, following Meta-analysis Of Observational Studies in Epidemiology (MOOSE) protocol. Studies having pre-existing CVD and HTN data that described outcomes including mortality and invasive mechanical ventilation (IMV) utilization were selected. Using random-effects models, risk of composite poor outcomes (meta-analysis) and isolated mortality and IMV utilization (meta-regression) were evaluated. Pooled prevalence of CVD and HTN, correlation coefficient (r) and odds ratio (OR) were estimated. The forest plots and correlation plots were created using random-effects models. Results: Out of 29 studies (n=27,950) that met the criteria, 28 and 27 studies had data on CVD and HTN, respectively. Pooled prevalence of CVD was 18.2% and HTN was 32.7%. In meta-analysis, CVD (OR: 3.36; 95% CI: 2.29-4.94) and HTN (OR: 1.94; 95% CI: 1.57-2.40) were associated with composite poor outcome. In age-adjusted meta-regression, pre-existing CVD was having significantly higher correlation of IMV utilization (r: 0.28; OR: 1.3; 95% CI: 1.1-1.6) without having any association with mortality (r: -0.01; OR: 0.9; 95% CI: 0.9-1.1) among COVID-19 hospitalizations. HTN was neither correlated with higher IMV utilization (r: 0.01; OR: 1.0; 95% CI: 0.9-1.1) nor correlated with higher mortality (r: 0.001; OR: 1.0; 95% CI: 0.9-1.1). Conclusion: In age-adjusted analysis, though we identified pre-existing CVD as a risk factor for higher utilization of mechanical ventilation, pre-existing CVD and HTN had no independent role in increasing mortality. Cureus 2021-02-18 /pmc/articles/PMC7980770/ /pubmed/33763316 http://dx.doi.org/10.7759/cureus.13420 Text en Copyright © 2021, Chakinala et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Chakinala, Raja Chandra Shah, Chail D Rakholiya, Jigisha H Martin, Mehwish Kaur, Nirmaljot Singh, Harmandeep Okafor, Toochukwu L Nwodika, Chika Raval, Payu Yousuf, Salma Lakhani, Komal Yogarajah, Angelina Malik, Preeti Singh, Jagmeet Kichloo, Asim Patel, Urvish K COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title | COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title_full | COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title_fullStr | COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title_full_unstemmed | COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title_short | COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension |
title_sort | covid-19 outcomes amongst patients with pre-existing cardiovascular disease and hypertension |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980770/ https://www.ncbi.nlm.nih.gov/pubmed/33763316 http://dx.doi.org/10.7759/cureus.13420 |
work_keys_str_mv | AT chakinalarajachandra covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT shahchaild covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT rakholiyajigishah covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT martinmehwish covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT kaurnirmaljot covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT singhharmandeep covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT okafortoochukwul covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT nwodikachika covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT ravalpayu covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT yousufsalma covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT lakhanikomal covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT yogarajahangelina covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT malikpreeti covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT singhjagmeet covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT kichlooasim covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension AT patelurvishk covid19outcomesamongstpatientswithpreexistingcardiovasculardiseaseandhypertension |